Submit A Paper
Plenary Session
Session 1
Session 2
Session 3
Session 4
Session 5
Session 6
Session 7
Session 8
Session 9
Session 10
 
Antibodies and vaccine technology
 
Stem cell and RNAi technology
Target discovery and drug innovation
 
Generic drugs and "westernizing" Chinese Medicine
Legal & Regulatory lssues
 
Venture Capital & Financing Options
Biotechnology cooperation and application
 
Biomarkers and diagnosis
Translational medicine and clinical research
 
 
Economic Strategies and Policy trend in health care & 2008 China Pharmaceutical Industry Information
 
 
name Affiliation Title Topic
Avram Hershko Technion-Israel Inst. Tech. Distinguished Professor Roles of the ubiquitin system in health and disease
James C. Greenwood Biotechnology Industry Organization President TBD
Li Yan Merck & Co., Inc. Associate Director, Clinical Oncology Clinical Development of Monoclonal Antibody Therapeutics
Stephen A. Bent Foley & Lardner LLP Partner The Evolving Global Biologics Market: Intellectual Property and Regulatory Considerations.
Zeqi Zhou Egenix, Inc VP and Chief Scientific Office Antibody Technology for Immunotherapy of Ovarian Cancer
Monique ALRIC University of Auvergne Professor Recombinant living yeasts as a new drug delivery system: in vitro and in vivo validation of the concept and development of oral dosage forms.
Kirk R. Smith University of California Professor Climate Change: Mitigating, Adapting, and Suffering -- How Much of Each?
Shu Chien UCSD Professor Translational Medicine Global Trend and China Opportunities
William J. Rutter Synergenics, LLC Chairman Future Opportunities for the Biotech Industr
Erik Kakes Applikon Biotechnology BV International Sales & Marketing Director Innovative technology for cell culture
C. Satishchandran Nucleonics, Inc. Co-Founder, COO & Executive VP Advancing RNAi-based Therapeutic from Discovery to clinic
Nikolay Alekseevich Zorin Institute of Basic Biological Problems,Russian Academy of Sciences Principal research scientist Thermostable hydrogenase from Thiocapsa roseopersicina: catalytic properties and biotechnological potential.
Sailen Barik University of South Alabama Professor Second generation intranasal siRNA therapy
Dale M. Edgar Eli Lilly & Company Executive Director & CSL, Discovery Sleep Research Applying In Vivo Discovery Technologies to Improve Patient Outcomes in Sleep Disorders Research
Gondi Kumar Celgene Corporation Senior Director - DMPK Contribution of Drug Metabolizing Enzymes to the Inter-individual Variability of Pharmacokinetics
Sofie Qiao LEAD Therapeutics, Inc. President and COO LEAD ¨C Designed and Created to Meet Unmet Needs in the Pharmaceutical Industry
 
home    Next    Previous    Last Page     Total1PageˇˇCurrent Page:1
 
The 10th Shanghai International Forum on Biotechnology and Pharmacy